Victory Capital Management’s Lyell Immunopharma LYEL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,148
| Closed | -$8.15K | – | 2521 |
|
|
2025
Q1 | $8.15K | Sell |
15,148
-2,697
| -15% | -$1.45K | ﹤0.01% | 2461 |
|
|
2024
Q4 | $11.4K | Buy |
17,845
+3,442
| +24% | +$2.2K | ﹤0.01% | 2467 |
|
|
2024
Q3 | $19.9K | Sell |
14,403
-893
| -6% | -$1.23K | ﹤0.01% | 2445 |
|
|
2024
Q2 | $22.2K | Sell |
15,296
-48
| -0.3% | -$70 | ﹤0.01% | 2424 |
|
|
2024
Q1 | $34.2K | Sell |
15,344
-1,275
| -8% | -$2.84K | ﹤0.01% | 2407 |
|
|
2023
Q4 | $32.2K | Buy |
16,619
+3,377
| +26% | +$6.55K | ﹤0.01% | 2476 |
|
|
2023
Q3 | $19.5K | Buy |
13,242
+137
| +1% | +$201 | ﹤0.01% | 2448 |
|
|
2023
Q2 | $41.7K | Sell |
13,105
-303
| -2% | -$964 | ﹤0.01% | 2403 |
|
|
2023
Q1 | $31.6K | Buy |
+13,408
| New | +$31.6K | ﹤0.01% | 2479 |
|
|
2022
Q3 | – | Sell |
-23,167
| Closed | -$151K | – | 2739 |
|
|
2022
Q2 | $151K | Sell |
23,167
-169,450
| -88% | -$1.1M | ﹤0.01% | 2403 |
|
|
2022
Q1 | $975K | Sell |
192,617
-13,761
| -7% | -$69.7K | ﹤0.01% | 1826 |
|
|
2021
Q4 | $1.6M | Sell |
206,378
-3,506
| -2% | -$27.1K | ﹤0.01% | 1638 |
|
|
2021
Q3 | $3.11M | Buy |
209,884
+17,044
| +9% | +$252K | ﹤0.01% | 1456 |
|
|
2021
Q2 | $3.13M | Buy |
+192,840
| New | +$3.13M | ﹤0.01% | 1498 |
|